CI Medical Co (TSE:3540) ROCE %: 24.44% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3540 CI Medical Co Ltd TSE:3540
70 GF Score
Price 円1,492.00
GF Value 円2,121.23
! 9 Warning Signs
View Full Analysis

What is CI Medical Co ROCE %?

CI Medical Co TSE:3540 70 ROCE % is 24.44% as of Jun. 2025. GuruFocus rates TSE:3540 with a GF Score™ of 70/100 and a GF Value™ of 円2,121.23. The stock has 9 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CI Medical Co's annualized ROCE % for the quarter that ended in Jun. 2025 was 24.44%.

CI Medical Co  (TSE:3540) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CI Medical Co ROCE % Related Terms

CI Medical Co ROCE % Historical Data

* Premium members only.

The historical data trend for CI Medical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CI Medical Co ROCE % Chart

CI Medical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.87 29.61 21.94 16.25 28.10

CI Medical Co Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.69 12.89 9.02 48.43 24.44
TSE:3540
70GF Score
CI Medical Co Ltd TSE:3540
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CI Medical Co ROCE % Calculation

CI Medical Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=7139/( ( (41506 - 20869) + (63166 - 32991) )/ 2 )
=7139/( (20637+30175)/ 2 )
=7139/25406
=28.10 %

CI Medical Co's ROCE % of for the quarter that ended in Jun. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2025 )  (Q: Dec. 2024 )(Q: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2025 )  (Q: Dec. 2024 )(Q: Jun. 2025 )
=7904/( ( (63166 - 32991) + (50978 - 16461) )/ 2 )
=7904/( ( 30175 + 34517 )/ 2 )
=7904/32346
=24.44 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 24.44% mean?
CI Medical Co (TSE:3540) has a ROCE % of 24.44% as of Jun. 2025.
Is CI Medical Co's ROCE % too high?
CI Medical Co's current ROCE % is 24.44%. The Consumer Packaged Goods industry median ROCE % is 8.88. CI Medical Co's value of 24.44% is 175.2% above this industry median. Overall, CI Medical Co has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does CI Medical Co's ROCE % compare to PG and CL?
CI Medical Co's ROCE % of 24.44% can be compared against companies in the Consumer Packaged Goods industry. The industry median ROCE % is 8.88. CI Medical Co's value of 24.44% is 175.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Consumer Packaged Goods company?
The median ROCE % among Consumer Packaged Goods companies is 8.88, based on 1,942 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CI Medical Co's current ROCE % of 24.44% is 175.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median ROCE % is 8.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CI Medical Co's current ROCE % is 24.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CI Medical Co stock overvalued right now?
CI Medical Co (TSE:3540) has a current ROCE % of 24.44%. The stock's GF Value™ is 円2,121.23, compared to a current price of 円1,492.00 — trading 29.7% below its estimated fair value. The current ROCE % is 24.44% and 175.2% above the Consumer Packaged Goods industry median of 8.88. CI Medical Co's overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For CI Medical Co (TSE:3540), the current ROCE % is 24.44% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CI Medical Co (TSE:3540) Overvalued in 2026?

Based on GuruFocus' analysis, CI Medical Co stock appears to be undervalued. The current stock price of 円1,492.00 is trading 29.7% below its estimated GF Value™ of 円2,121.23.

Key valuation signals for TSE:3540:

  • ROCE %: 24.44%
  • GF Value™: 円2,121.23 vs. price of 円1,492.00 (29.7% below fair value)
  • GF Score™: 70/100 with 9 warning signs
  • Industry Position: 175.2% above the Consumer Packaged Goods median

No single metric tells the full story. See the TSE:3540 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CI Medical Co Business Description

Address 2-6 Asahigaoka, Hakusan, Ishikawa, JPN, 924-0004
CI Medical Co Ltd engages in the development, manufacturing, and sales of dental care products. It operates 3D design labs; it offers advertising and marketing services through its website "Dental Mall" and also manages oral health care website "Ci Mall" and "Dental Fit" through which it sells oral health products and dentures. It serves medical cooperatives, dental clinics, dental associations, health centers, dental colleges, veterinary clinics, nursing home care facilities, and dental dealers.
70GF Score

Get the complete analysis for TSE:3540

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,492.00
Price
円2,121.23
GF Value